Literature DB >> 1912416

Virulence and pathogenicity of Helicobacter pylori.

B J Marshall1.   

Abstract

H. pylori is a highly virulent organism as evidenced by its low infective dose and widespread high prevalence in human populations. Its virulence is achieved through its ability to survive in a moist environment and its massive urease production which allows it to survive in the acidic gastric juice long enough to colonize the gastric mucus. Gastric colonization is facilitated by cell wall associated lectins which permit the bacterium to bind to gastric mucus and the gastric epithelial cell. Once in this location, H. pylori produces several enzymes which may harm the gastric epithelium, particularly urease (through ammonia generation) and phospholipases A and C. H. pylori also weakens the gastric mucous layer by digesting its glycoproteins and lipids, making the mucus less hydrophobic and more water soluble. Helicobacter pylori attracts phagocytic cells, inducing both acute and chronic inflammation as well as an antibody response. Persistence of H. pylori in the mucosa may be enhanced by its cytotoxin and catalase production, by which it survives after phagocytosis by neutrophils.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1912416     DOI: 10.1111/j.1440-1746.1991.tb01450.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

Review 1.  Formulary management of antiulcer drugs: clinical considerations.

Authors:  S L Sankey; L S Friedman
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

2.  H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor?

Authors:  G Holtmann; J Gschossmann; M Holtmann; N J Talley
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

3.  Effects of inflammatory cytokines induced by Helicobacter pylori infection on aminopyrine accumulation in parietal cells isolated from guinea pigs.

Authors:  N Tani; Y Watanabe; T Suzuki; S Muramatsu; M Miyazawa; N Kimura; T Miwa
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

Review 4.  Pathogenicity of Helicobacter pylori: a perspective.

Authors:  A Lee; J Fox; S Hazell
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Ascorbic acid secretion in the human stomach and the effect of gastrin.

Authors:  Bi-Guang Tuo; Yong-Hui Yan; Zheng-Long Ge; Gang-Wei Ou; Kui Zhao
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

6.  Agglutination of Helicobacter pylori coccoids by lectins.

Authors:  Mar Mar Khin; Jie-Song Hua; Han-Cong Ng; Torkel Wadstrom; Ho Bow
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

7.  In Vitro and In Vivo Antibacterial Activities of Patchouli Alcohol, a Naturally Occurring Tricyclic Sesquiterpene, against Helicobacter pylori Infection.

Authors:  Y F Xu; D W Lian; Y Q Chen; Y F Cai; Y F Zheng; P L Fan; W K Ren; L J Fu; Y C Li; J H Xie; H Y Cao; B Tan; Z R Su; P Huang
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

8.  Phase variation in the Helicobacter pylori phospholipase A gene and its role in acid adaptation.

Authors:  T Tannaes; N Dekker; G Bukholm; J J Bijlsma; B J Appelmelk
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  Purification and characterization of the urease enzymes of Helicobacter species from humans and animals.

Authors:  G R Turbett; P B Høj; R Horne; B J Mee
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

10.  Ammonia inhibits proliferation and cell cycle progression at S-phase in human gastric cells.

Authors:  T Matsui; Y Matsukawa; T Sakai; K Nakamura; A Aoike; K Kawai
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.